Experimental radioactive Hodgkin's therapy shows promise in Phase I trial

Submitted by Ross Bonander Wed 12/16/2009

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Researchers are encouraged by the results of a small, Phase I experimental trial of a targeted, radioactive monoclonal antibody in patients with relapsed or refractory Hodgkin's lymphoma known as I-CHT25.

The small trial only involved a handful of patients, but according to results published in the journal Clinical Cancer Research, two thirds of patients had complete response to the therapy, in which cancer cells were exposed to radioactive isotopes for as many as four days without ostensible damage to surrounding tissue.

The experimental therapy appears to function similarly to Bexxar and Zevalin.

The study was backed by Cancer Research UK's Experimental Cancer Medicine Centre at University College London, and development of a Phase II trial for I-CHT25 is underway.

By Ross Bonander

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.